1. Aman MG, Singh NN (1985) Dyskinetic symptoms in profoundly retarded residents following neuroleptic withdrawal and during methylphenidate treatment. Journal of Mental Deficiency Research 29: 187–195
2. Aman MG, White AJ (1988) Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents. Journal of Autism and Developmental Disorders 18: 355–366
3. Aman MG, Marks R, Turbott S, Wilsher CP, Merry SN (1991a) Clinical effects of methylphenidate and thioridazine in intellectually subaverage children. Journal of the American Academy of Child and Adolescent Psychiatry 30: 246–256
4. Aman MG, Marks R, Turbott S, Wilsher CP, Merry SN (1991) Methylphenidate and thioridazine in the treatment of intellectually subaverage children: effects on cognitive-motor performance. Journal of the American Academy of Child and Adolescent Psychiatry 30: 816–824
5. Aman MG, Teehan CJ, White AJ, Turbott SH, Vaithianathan C (1989) Haloperidol treatment with chronically medicated residents: dose effects on clinical behavior and reinforcement contingencies. American Journal of Mental Retardation 93: 452–460